Evidence map›Paper›PMID 32905722›Full record

ArticleGlobal spine journal2020

Use of Fondaparinux Following Elective Lumbar Spine Surgery Is Associated With a Reduction in Symptomatic Venous Thromboembolism.

Mitchell S Fourman, Jeremy D Shaw, Chinedu O Nwasike, Lorraine A T Boakye, Malcolm E Dombrowski, Nicholas J Vaudreuil, Richard A Wawrose, David J Lunardini, Joon Y Lee

Open access · goldAbstract read
In one paragraph

Article in Global spine journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Off-Label Bone Morphogenetic Protein 2 Use Results in Successful Posterolateral Lumbar Fusion in a Veteran Population.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mitchell S Fourman6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID https://orcid.org/0000-0001-5886-546X
Jeremy D Shaw6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Chinedu O Nwasike6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Lorraine A T Boakye6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Malcolm E Dombrowski6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Nicholas J Vaudreuil6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Richard A Wawrose6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
David J Lunardini2090University of Vermont Medical Center, Burlington, VT, USA.
Joon Y Lee6595University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
University of Pittsburgh Medical Center · USUniversity of Vermont Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

designRetrospective cohort study.

objectiveTo assess the impact of fondaparinux on venous thromboembolism (VTE) following elective lumbar spine surgery in high-risk patients.

methodsMatched patient cohorts who did or did not receive inpatient fondaparinux starting postoperative day 2 following elective lumbar spine surgery were compared. All patients received 1 month of acetyl salicylic acid 325 mg following discharge. The primary outcome was a symptomatic DVT (deep vein thrombosis) or PE (pulmonary embolus) within 30 days of surgery. Secondary outcomes included prolonged wound drainage, epidural hematoma, and transfusion.

resultsA significantly higher number of DVTs were diagnosed in the group that did not receive inpatient VTE prophylaxis (3/102, 2.9%) compared with the fondaparinux group (0/275, 0%,

conclusionsPatients receiving fondaparinux had lower rates of symptomatic DVT and PE and a favorable complication profile when compared with matched controls. The retrospective nature of this work limits the safety and efficacy claims that can be made about the use of fondaparinux to prevent VTE in elective lumbar spine surgery patients. Importantly, this work highlights the potential safety of this regimen, permitting future high-quality trials.

Indexed as

adult spinedeep vein thrombosisfondaparinuxhigh-riskpulmonary embolismvenous thromboembolism prophylaxis

Identifiers

PMID32905722
PMCPMC7485070
OpenAlexW2979254741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.